Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Turner

Showing results (61-70 of 1,647) with videos related to

Pageof 165
Sort By:
Journal of the Royal Society of Medicine|November 1, 1991
Which ancillary properties of beta-adrenoceptor blocking drugs influence their therapeutic or adverse effects?: a reviewP Turner
Journal of the Royal Society of Medicine|July 1, 1987
Clinical pharmacology in criminal cases: discussion paperP Turner
Human & Experimental Toxicology|January 1, 1990
Human toxicology and the British Toxicology Society--a closer associationP Turner
Proceedings of the Royal Society of Medicine|December 9, 2009
Lumbar HerniaP Turner
Proceedings of the Royal Society of Medicine|December 9, 2009
Seasonal Enlargement of the Parotid GlandsP Turner
British Journal of Clinical Pharmacology|January 1, 1986
Profitability and improved patient care--the physician's viewpointP Turner
Postgraduate Medical Journal|January 1, 1989
Therapeutic uses of beta-adrenoceptor blocking drugs in the central nervous system in manP Turner
Nursing Times|June 15, 1994
Pension rites. Interview by Phil CohenP Turner
Clinical Neuropharmacology|January 1, 1988
Human implications of animal experiments--lessons from dexfenfluramineP Turner
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|June 21, 2016
Self protectionP Turner
Pageof 165

Showing results (61-70 of 1,647) with videos related to

Sort By:
Pageof 165
Journal of the Royal Society of Medicine|November 1, 1991
Which ancillary properties of beta-adrenoceptor blocking drugs influence their therapeutic or adverse effects?: a reviewP Turner
Journal of the Royal Society of Medicine|July 1, 1987
Clinical pharmacology in criminal cases: discussion paperP Turner
Human & Experimental Toxicology|January 1, 1990
Human toxicology and the British Toxicology Society--a closer associationP Turner
Proceedings of the Royal Society of Medicine|December 9, 2009
Lumbar HerniaP Turner
Proceedings of the Royal Society of Medicine|December 9, 2009
Seasonal Enlargement of the Parotid GlandsP Turner
British Journal of Clinical Pharmacology|January 1, 1986
Profitability and improved patient care--the physician's viewpointP Turner
Postgraduate Medical Journal|January 1, 1989
Therapeutic uses of beta-adrenoceptor blocking drugs in the central nervous system in manP Turner
Nursing Times|June 15, 1994
Pension rites. Interview by Phil CohenP Turner
Clinical Neuropharmacology|January 1, 1988
Human implications of animal experiments--lessons from dexfenfluramineP Turner
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|June 21, 2016
Self protectionP Turner
Pageof 165